T. Tokui

561 total citations
15 papers, 483 citations indexed

About

T. Tokui is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, T. Tokui has authored 15 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in T. Tokui's work include Radiopharmaceutical Chemistry and Applications (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). T. Tokui is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). T. Tokui collaborates with scholars based in Japan, United States and Germany. T. Tokui's co-authors include Toshihiko Komai, Daisuke Nakai, Hiroshi Suzuki, Yuichi Sugiyama, M Hanano, Mami Yamazaki, Chairat Shayakul, Matthias A. Hediger, Urs V. Berger and Dennis Brown and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Oncology and Life Sciences.

In The Last Decade

T. Tokui

15 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Tokui Japan	8	204	156	133	121	79	15	483
Paul G. Killenberg United States	15	151 0.7×	156 1.0×	127 1.0×	59 0.5×	120 1.5×	28	1.1k
R. Stephens United Kingdom	11	227 1.1×	154 1.0×	65 0.5×	140 1.2×	51 0.6×	18	529
Alfons C. Wouterse Netherlands	12	286 1.4×	267 1.7×	70 0.5×	176 1.5×	62 0.8×	30	659
A.M. Jézéquel Italy	14	187 0.9×	203 1.3×	155 1.2×	59 0.5×	206 2.6×	40	953
Srinivasa Rao Jada Singapore	11	306 1.5×	238 1.5×	165 1.2×	83 0.7×	35 0.4×	18	652
Takuro Niwa Japan	11	436 2.1×	219 1.4×	188 1.4×	207 1.7×	140 1.8×	16	824
Priyamvada Chandra United States	9	310 1.5×	59 0.4×	162 1.2×	145 1.2×	77 1.0×	14	454
William J. Jusko United States	13	90 0.4×	190 1.2×	118 0.9×	86 0.7×	59 0.7×	17	607
Jerry McGrath Canada	9	319 1.6×	99 0.6×	92 0.7×	131 1.1×	75 0.9×	21	634
H. Dralle Germany	11	194 1.0×	191 1.2×	95 0.7×	102 0.8×	156 2.0×	32	711

Countries citing papers authored by T. Tokui

Since Specialization

Citations

This map shows the geographic impact of T. Tokui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Tokui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Tokui more than expected).

Fields of papers citing papers by T. Tokui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Tokui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Tokui. The network helps show where T. Tokui may publish in the future.

Co-authorship network of co-authors of T. Tokui

This figure shows the co-authorship network connecting the top 25 collaborators of T. Tokui. A scholar is included among the top collaborators of T. Tokui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Tokui. T. Tokui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zahir, Hamim, Ronald E. Savage, Giovanni Abbadessa, et al.. (2012). Exposure-Response Relationship to Assess the Risk of Neutropenia in Patients with Hepatocellular Carcinoma (HCC) Treated with Tivantinib. Annals of Oncology. 23. ix244–ix245. 6 indexed citations

Kotsuma, Masakatsu, T. Tokui, Stefan Freudenthaler, & Kunihiro Nishimura. (2008). Effect of CYP2D6 polymorphism on pharmacokinetics of a novel ACAT inhibitor, pactimibe and its unique metabolite, R-125528. International Journal of Clinical Pharmacology and Therapeutics. 46(11). 545–555. 1 indexed citations

Nakai, Daisuke, et al.. (2007). Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1. Xenobiotica. 37(5). 474–486. 49 indexed citations

Nakai, Daisuke, et al.. (2007). Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica. 37(4). 416–426. 57 indexed citations

T, Abe, et al.. (2001). [Molecular identification of organic anion transporter oatp/LST family].. PubMed. 46(5). 612–20. 4 indexed citations

Kawai, Kenji, et al.. (1998). Stereoselective Metabolism of New Oral Anti-diabetic Agent Troglitazone Stereoisomers in Liver.. Drug Metabolism and Pharmacokinetics. 13(4). 362–368. 8 indexed citations

Tsukaguchi, Hiroyasu, Chairat Shayakul, Urs V. Berger, et al.. (1997). Cloning and characterization of the urea transporter UT3: localization in rat kidney and testis.. Journal of Clinical Investigation. 99(7). 1506–1515. 105 indexed citations

Yamazaki, Mami, Hiroshi Suzuki, M Hanano, et al.. (1993). Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 264(1). G36–G44. 142 indexed citations

Saji, Hideo, T. Tokui, Iwao Nakatsuka, et al.. (1992). Evaluation of N-Alkyl Derivatives of Radioiodinated Spiperone as Radioligands for in Vivo Dopamine D2 Receptor Studies: Effects of Lipophilicity and Receptor Affinity on the in Vivo Biodistribution.. Chemical and Pharmaceutical Bulletin. 40(1). 165–169. 6 indexed citations

10.

Komai, Toshihiko, et al.. (1992). Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys. European Journal of Drug Metabolism and Pharmacokinetics. 17(2). 103–113. 57 indexed citations

11.

Saji, Hideo, Akihiko Saiga, T. Tokui, et al.. (1989). Survey on N‐alkyl 2′‐iodospiperone derivatives: Effect of lipophilicity and dopamine receptor binding affinity on in vivo biodistribution. Journal of Labelled Compounds and Radiopharmaceuticals. 26(1-12). 95–97. 4 indexed citations

12.

Saji, Hideo, Iwao Nakatsuka, T. Tokui, et al.. (1987). Radioiodinated 2′-iodospiperone: A new radioligand for in vivo dopamine receptor study. Life Sciences. 41(17). 1999–2006. 17 indexed citations

13.

Kaaden, O.‐R., et al.. (1971). [Concentration and purification of foot-and-mouth disease (FMD) virus by polyethylenglycol (PEG)].. PubMed. 35(1). 104–13. 6 indexed citations

14.

Dietzschold, B, O.‐R. Kaaden, T. Tokui, & H. O. Böhm. (1971). Polynucleotide Sequence Homologies among the RNAs of Foot-and-Mouth Disease Virus Types A, C and O. Journal of General Virology. 13(1). 1–7. 16 indexed citations

15.

Kaaden, O.‐R., et al.. (1971). Konzentrierung und Reinigung von Maul-und-Klauenseuche-(MKS-) Virus durch Poly�thylenglykol (PEG). Archives of Virology. 35(1). 104–113. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact